QEII Health Science Centre
Welcome,         Profile    Billing    Logout  
 16 Trials 
32 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Shivakumar, Sudeep
COBRRA, NCT03266783: Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism

Recruiting
4
2760
Europe, Canada, RoW
Apixaban, Eliquis, Rivaroxaban, Xarelto
Ottawa Hospital Research Institute, Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network, Canadian Institutes of Health Research (CIHR)
Venous Thromboembolism
12/24
12/24
MUFFIN-PTS, NCT03833024: The Trial

Active, not recruiting
3
88
Canada
Micronized Purified Flavonoid Fraction, Venixxa group, Placebo, Placebo group
Sir Mortimer B. Davis - Jewish General Hospital
Post-Thrombotic Syndrome
03/24
05/24
EPCATIII, NCT04075240: VTE Prevention Following Total Hip and Knee Arthroplasty

Recruiting
3
5400
Canada
Rivaroxaban 10 MG and acetylsalicylic acid 81 mg, Xarelto 10mg and aspirin 81mg, acetylsalicylic acid 81 mg, aspirin 81mg
Sudeep Shivakumar, Canadian Institutes of Health Research (CIHR), Nova Scotia Health Authority, Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network
Venous Thromboembolism
12/25
04/26
SAVER, NCT04319627 / 2021-001559-15: Statins for Venous Event Reduction in Patients With Venous Thromboembolism

Recruiting
3
2700
Europe, Canada
Rosuvastatin Calcium, Rosuvastatin, Placebo Oral Tablet, Placebo
Ottawa Hospital Research Institute, The Canadian Institutes of Health Research (CIHR)
Venous Thromboembolism, Blood Clot, Post Thrombotic Syndrome
01/26
01/27
WAVe, NCT03297359: Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism

Terminated
2
92
Canada
Dalteparin
Ottawa Hospital Research Institute, Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network
Cancer, Venous Thromboembolism, Obesity
11/23
11/23
PAUSE Virtual, NCT06844227: Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)

Recruiting
N/A
1780
Europe, Canada, US
McMaster University
Atrial Fibrillation (AF)
12/25
12/26
Sapp, John L
VANISH2, NCT02830360: Antiarrhythmics or Ablation for Ventricular Tachycardia 2

Completed
4
416
Europe, Canada, US
Antiarrythmic Drug Therapy, Amiodarone (Cordarone) or Sotalol (Sotacor), Catheter ablation, VT ablation
John Sapp, Heart and Stroke Foundation of Canada, Abbott Medical Devices, Biosense Webster, Inc., Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR), Cardiac Arrhythmia Network of Canada, Abbott, Nova Scotia Health Authority
Ventricular Tachycardia (VT)
06/24
06/24
REFINE-ICD, NCT00673842: Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction

Active, not recruiting
3
700
Europe, Canada, US, RoW
Implantable Cardioverter Defibrillator + Usual Care, Implantable Cardioverter Defibrillator, ICD, Usual care, Standard medical therapy alone
University of Calgary, Canadian Institutes of Health Research (CIHR), Alberta Innovation and Science, Medtronic, GE Healthcare, Cardiac Arrhythmia Network of Canada, Accelerating Clinical Trials Consortium
Myocardial Infarction, Sudden Death
12/24
12/24
COAST-AF RCT, NCT03347227: Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation

Recruiting
N/A
502
Canada
Catheter ablation, Atrial Fibrillation Ablation
Ottawa Heart Institute Research Corporation, Heart and Stroke Foundation of Canada
Atrial Fibrillation
12/24
12/24
ECGI-VT, NCT03713866: Peri-Procedural Transmural Electrophysiological (EP) Imaging of Scar-Related Ventricular Tachycardia

Recruiting
N/A
20
Canada
EP Imaging and Testing
John Sapp, Nova Scotia Health Authority, Rochester Institute of Technology
Ventricular Tachycardia, Myocardial Infarction
12/26
03/27
RASTA AF, NCT03682991: Reversal of Atrial Substrate to Prevent Atrial

Recruiting
N/A
670
Canada
Aggressive Risk Factor Control, Standard of Care
Nova Scotia Health Authority, Canadian Institutes of Health Research (CIHR), Abbott, Phillips, Cardiac Arrhythmia Network of Canada
Atrial Fibrillation
06/25
06/27
NCT04162171: Cohort Study - SBRT for VT Radioablation

Recruiting
N/A
12
Canada
Stereotactic Body Radiotherapy (SBRT) ablation of VT, VT Radioablation
John Sapp
Ventricular Tachycardia, Myocardial Infarction, Heart Disease Structural Disorder
06/26
09/26
END VT, NCT05835791: END - VT Cohort Study

Recruiting
N/A
2454
Canada
Nova Scotia Health Authority, Maritime Heart Centre
Ventricular Tachycardia, Implantable Defibrillator User, ICD
04/28
04/29
Parkash, Ratika
VANISH2, NCT02830360: Antiarrhythmics or Ablation for Ventricular Tachycardia 2

Completed
4
416
Europe, Canada, US
Antiarrythmic Drug Therapy, Amiodarone (Cordarone) or Sotalol (Sotacor), Catheter ablation, VT ablation
John Sapp, Heart and Stroke Foundation of Canada, Abbott Medical Devices, Biosense Webster, Inc., Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR), Cardiac Arrhythmia Network of Canada, Abbott, Nova Scotia Health Authority
Ventricular Tachycardia (VT)
06/24
06/24
OCEAN, NCT02168829 / 2016-002353-38: Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial

Active, not recruiting
4
1284
Europe, Canada, RoW
Rivaroxaban, Xarelto, Acetylsalicylic acid, Aspirin, ASA
Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR), Bayer, Biotronik Canada Inc
Atrial Fibrillation, Stroke
07/25
08/25
COBRRA AF, NCT04642430: COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation

Recruiting
4
3018
Canada
Apixaban, Eliquis, Rivaroxaban, Xarelto
Ottawa Hospital Research Institute, Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network, Canadian Institutes of Health Research (CIHR)
Atrial Fibrillation
12/26
12/26
BRAIN-AF, NCT02387229: Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF

Terminated
3
1238
Canada
Rivaroxaban, Xarelto, standard of care
Montreal Heart Institute, Canadian Stroke Prevention Intervention Network, The Montreal Health Innovations Coordinating Center (MHICC), Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma, Montreal Heart Institute Foundation, Canadian Institutes of Health Research (CIHR), Hewitt Foundation
ATRIAL FIBRILLATION
05/24
05/24
ICD-GDMT, NCT04505007: Guideline-Directed Medical Therapy in Patients After Implantation of Implantable Cardioverter Defibrillators to Improve Long-Term Outcomes

Active, not recruiting
N/A
29
Canada
Specialized heart function clinic
Ratika Parkash, Nova Scotia Health Authority
Heart Failure, ICD
12/23
08/24
RAFT-AF Extend, NCT05118893: Randomized Ablation-based AF Rhythm-control Versus Rate-control in Patients With HF and High-burden AF Extend

Completed
N/A
324
Canada
Anthony Tang
Atrial Fibrillation, Heart Failure
08/24
08/24
NCT04599114: Virtual for Care Atrial Fibrillation Patients Using VIRTUES

Not yet recruiting
N/A
300
Canada
VIRTUES
Lawson Health Research Institute, Cardiac Arrhythmia Network of Canada
Atrial Fibrillation
11/23
11/24
RAFT-PermAF, NCT01994252: Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation

Active, not recruiting
N/A
200
Canada
Optimal Medical therapy plus ICD, Optimal Medical therapy plus CRT/ICD
Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR)
Heart Disease, Congestive Heart Failure, Atrial Fibrillation
09/24
09/24
RASTA-Cohort, NCT06249269: Reversal of Atrial Substrate to Prevent Atrial Fibrillation Cohort Study

Recruiting
N/A
198
Canada
Ratika Parkash, Nova Scotia Health Research Fund
Atrial Fibrillation, Paroxysmal or Persistent
12/26
03/27
RASTA AF, NCT03682991: Reversal of Atrial Substrate to Prevent Atrial

Recruiting
N/A
670
Canada
Aggressive Risk Factor Control, Standard of Care
Nova Scotia Health Authority, Canadian Institutes of Health Research (CIHR), Abbott, Phillips, Cardiac Arrhythmia Network of Canada
Atrial Fibrillation
06/25
06/27
RPM CIED Tachy, NCT03405740: Remote Patient Management of CIEDs

Recruiting
N/A
1164
Canada
Remote Patient Management, Standard of Care
Ratika Parkash, Cardiac Arrhythmia Network of Canada, Abbott Medical Devices, Medtronic
Cardiac Arrhythmia
02/25
06/25
NCT03636230: Remote Patient Management of CIEDs - Brady Devices

Recruiting
N/A
848
Canada
Remote Monitoring, Standard of care
Ratika Parkash, Cardiac Arrhythmia Network of Canada, Medtronic, Abbott
Pacemaker
02/25
06/25
Wan, Tony
COBRRA, NCT03266783: Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism

Recruiting
4
2760
Europe, Canada, RoW
Apixaban, Eliquis, Rivaroxaban, Xarelto
Ottawa Hospital Research Institute, Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network, Canadian Institutes of Health Research (CIHR)
Venous Thromboembolism
12/24
12/24
Woodburn, May
COBRRA AF, NCT04642430: COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation

Recruiting
4
3018
Canada
Apixaban, Eliquis, Rivaroxaban, Xarelto
Ottawa Hospital Research Institute, Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network, Canadian Institutes of Health Research (CIHR)
Atrial Fibrillation
12/26
12/26
CATCH-AF, NCT04302311: Early Diagnosis of Atrial Fibrillation in the Wait-Time Prior to Seeing a Cardiologist

Active, not recruiting
N/A
73
Canada
Holter monitoring, Atrial Fibrillation Diagnostic Testing, Kardia/AliveCor monitoring
Victoria Cardiac Arrhythmia Trials
Atrial Fibrillation, Atrial Fibrillation Paroxysmal, Arrhythmias, Cardiac, Cardiovascular Diseases
10/22
03/24
RPM CIED Tachy, NCT03405740: Remote Patient Management of CIEDs

Recruiting
N/A
1164
Canada
Remote Patient Management, Standard of Care
Ratika Parkash, Cardiac Arrhythmia Network of Canada, Abbott Medical Devices, Medtronic
Cardiac Arrhythmia
02/25
06/25
NCT03636230: Remote Patient Management of CIEDs - Brady Devices

Recruiting
N/A
848
Canada
Remote Monitoring, Standard of care
Ratika Parkash, Cardiac Arrhythmia Network of Canada, Medtronic, Abbott
Pacemaker
02/25
06/25
Samuel, Michelle
END VT, NCT05835791: END - VT Cohort Study

Recruiting
N/A
2454
Canada
Nova Scotia Health Authority, Maritime Heart Centre
Ventricular Tachycardia, Implantable Defibrillator User, ICD
04/28
04/29
Greeley, Suzanne
END VT, NCT05835791: END - VT Cohort Study

Recruiting
N/A
2454
Canada
Nova Scotia Health Authority, Maritime Heart Centre
Ventricular Tachycardia, Implantable Defibrillator User, ICD
04/28
04/29
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Shivakumar, Sudeep
COBRRA, NCT03266783: Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism

Recruiting
4
2760
Europe, Canada, RoW
Apixaban, Eliquis, Rivaroxaban, Xarelto
Ottawa Hospital Research Institute, Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network, Canadian Institutes of Health Research (CIHR)
Venous Thromboembolism
12/24
12/24
MUFFIN-PTS, NCT03833024: The Trial

Active, not recruiting
3
88
Canada
Micronized Purified Flavonoid Fraction, Venixxa group, Placebo, Placebo group
Sir Mortimer B. Davis - Jewish General Hospital
Post-Thrombotic Syndrome
03/24
05/24
EPCATIII, NCT04075240: VTE Prevention Following Total Hip and Knee Arthroplasty

Recruiting
3
5400
Canada
Rivaroxaban 10 MG and acetylsalicylic acid 81 mg, Xarelto 10mg and aspirin 81mg, acetylsalicylic acid 81 mg, aspirin 81mg
Sudeep Shivakumar, Canadian Institutes of Health Research (CIHR), Nova Scotia Health Authority, Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network
Venous Thromboembolism
12/25
04/26
SAVER, NCT04319627 / 2021-001559-15: Statins for Venous Event Reduction in Patients With Venous Thromboembolism

Recruiting
3
2700
Europe, Canada
Rosuvastatin Calcium, Rosuvastatin, Placebo Oral Tablet, Placebo
Ottawa Hospital Research Institute, The Canadian Institutes of Health Research (CIHR)
Venous Thromboembolism, Blood Clot, Post Thrombotic Syndrome
01/26
01/27
WAVe, NCT03297359: Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism

Terminated
2
92
Canada
Dalteparin
Ottawa Hospital Research Institute, Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network
Cancer, Venous Thromboembolism, Obesity
11/23
11/23
PAUSE Virtual, NCT06844227: Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)

Recruiting
N/A
1780
Europe, Canada, US
McMaster University
Atrial Fibrillation (AF)
12/25
12/26
Sapp, John L
VANISH2, NCT02830360: Antiarrhythmics or Ablation for Ventricular Tachycardia 2

Completed
4
416
Europe, Canada, US
Antiarrythmic Drug Therapy, Amiodarone (Cordarone) or Sotalol (Sotacor), Catheter ablation, VT ablation
John Sapp, Heart and Stroke Foundation of Canada, Abbott Medical Devices, Biosense Webster, Inc., Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR), Cardiac Arrhythmia Network of Canada, Abbott, Nova Scotia Health Authority
Ventricular Tachycardia (VT)
06/24
06/24
REFINE-ICD, NCT00673842: Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction

Active, not recruiting
3
700
Europe, Canada, US, RoW
Implantable Cardioverter Defibrillator + Usual Care, Implantable Cardioverter Defibrillator, ICD, Usual care, Standard medical therapy alone
University of Calgary, Canadian Institutes of Health Research (CIHR), Alberta Innovation and Science, Medtronic, GE Healthcare, Cardiac Arrhythmia Network of Canada, Accelerating Clinical Trials Consortium
Myocardial Infarction, Sudden Death
12/24
12/24
COAST-AF RCT, NCT03347227: Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation

Recruiting
N/A
502
Canada
Catheter ablation, Atrial Fibrillation Ablation
Ottawa Heart Institute Research Corporation, Heart and Stroke Foundation of Canada
Atrial Fibrillation
12/24
12/24
ECGI-VT, NCT03713866: Peri-Procedural Transmural Electrophysiological (EP) Imaging of Scar-Related Ventricular Tachycardia

Recruiting
N/A
20
Canada
EP Imaging and Testing
John Sapp, Nova Scotia Health Authority, Rochester Institute of Technology
Ventricular Tachycardia, Myocardial Infarction
12/26
03/27
RASTA AF, NCT03682991: Reversal of Atrial Substrate to Prevent Atrial

Recruiting
N/A
670
Canada
Aggressive Risk Factor Control, Standard of Care
Nova Scotia Health Authority, Canadian Institutes of Health Research (CIHR), Abbott, Phillips, Cardiac Arrhythmia Network of Canada
Atrial Fibrillation
06/25
06/27
NCT04162171: Cohort Study - SBRT for VT Radioablation

Recruiting
N/A
12
Canada
Stereotactic Body Radiotherapy (SBRT) ablation of VT, VT Radioablation
John Sapp
Ventricular Tachycardia, Myocardial Infarction, Heart Disease Structural Disorder
06/26
09/26
END VT, NCT05835791: END - VT Cohort Study

Recruiting
N/A
2454
Canada
Nova Scotia Health Authority, Maritime Heart Centre
Ventricular Tachycardia, Implantable Defibrillator User, ICD
04/28
04/29
Parkash, Ratika
VANISH2, NCT02830360: Antiarrhythmics or Ablation for Ventricular Tachycardia 2

Completed
4
416
Europe, Canada, US
Antiarrythmic Drug Therapy, Amiodarone (Cordarone) or Sotalol (Sotacor), Catheter ablation, VT ablation
John Sapp, Heart and Stroke Foundation of Canada, Abbott Medical Devices, Biosense Webster, Inc., Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR), Cardiac Arrhythmia Network of Canada, Abbott, Nova Scotia Health Authority
Ventricular Tachycardia (VT)
06/24
06/24
OCEAN, NCT02168829 / 2016-002353-38: Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial

Active, not recruiting
4
1284
Europe, Canada, RoW
Rivaroxaban, Xarelto, Acetylsalicylic acid, Aspirin, ASA
Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR), Bayer, Biotronik Canada Inc
Atrial Fibrillation, Stroke
07/25
08/25
COBRRA AF, NCT04642430: COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation

Recruiting
4
3018
Canada
Apixaban, Eliquis, Rivaroxaban, Xarelto
Ottawa Hospital Research Institute, Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network, Canadian Institutes of Health Research (CIHR)
Atrial Fibrillation
12/26
12/26
BRAIN-AF, NCT02387229: Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF

Terminated
3
1238
Canada
Rivaroxaban, Xarelto, standard of care
Montreal Heart Institute, Canadian Stroke Prevention Intervention Network, The Montreal Health Innovations Coordinating Center (MHICC), Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma, Montreal Heart Institute Foundation, Canadian Institutes of Health Research (CIHR), Hewitt Foundation
ATRIAL FIBRILLATION
05/24
05/24
ICD-GDMT, NCT04505007: Guideline-Directed Medical Therapy in Patients After Implantation of Implantable Cardioverter Defibrillators to Improve Long-Term Outcomes

Active, not recruiting
N/A
29
Canada
Specialized heart function clinic
Ratika Parkash, Nova Scotia Health Authority
Heart Failure, ICD
12/23
08/24
RAFT-AF Extend, NCT05118893: Randomized Ablation-based AF Rhythm-control Versus Rate-control in Patients With HF and High-burden AF Extend

Completed
N/A
324
Canada
Anthony Tang
Atrial Fibrillation, Heart Failure
08/24
08/24
NCT04599114: Virtual for Care Atrial Fibrillation Patients Using VIRTUES

Not yet recruiting
N/A
300
Canada
VIRTUES
Lawson Health Research Institute, Cardiac Arrhythmia Network of Canada
Atrial Fibrillation
11/23
11/24
RAFT-PermAF, NCT01994252: Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation

Active, not recruiting
N/A
200
Canada
Optimal Medical therapy plus ICD, Optimal Medical therapy plus CRT/ICD
Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR)
Heart Disease, Congestive Heart Failure, Atrial Fibrillation
09/24
09/24
RASTA-Cohort, NCT06249269: Reversal of Atrial Substrate to Prevent Atrial Fibrillation Cohort Study

Recruiting
N/A
198
Canada
Ratika Parkash, Nova Scotia Health Research Fund
Atrial Fibrillation, Paroxysmal or Persistent
12/26
03/27
RASTA AF, NCT03682991: Reversal of Atrial Substrate to Prevent Atrial

Recruiting
N/A
670
Canada
Aggressive Risk Factor Control, Standard of Care
Nova Scotia Health Authority, Canadian Institutes of Health Research (CIHR), Abbott, Phillips, Cardiac Arrhythmia Network of Canada
Atrial Fibrillation
06/25
06/27
RPM CIED Tachy, NCT03405740: Remote Patient Management of CIEDs

Recruiting
N/A
1164
Canada
Remote Patient Management, Standard of Care
Ratika Parkash, Cardiac Arrhythmia Network of Canada, Abbott Medical Devices, Medtronic
Cardiac Arrhythmia
02/25
06/25
NCT03636230: Remote Patient Management of CIEDs - Brady Devices

Recruiting
N/A
848
Canada
Remote Monitoring, Standard of care
Ratika Parkash, Cardiac Arrhythmia Network of Canada, Medtronic, Abbott
Pacemaker
02/25
06/25
Wan, Tony
COBRRA, NCT03266783: Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism

Recruiting
4
2760
Europe, Canada, RoW
Apixaban, Eliquis, Rivaroxaban, Xarelto
Ottawa Hospital Research Institute, Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network, Canadian Institutes of Health Research (CIHR)
Venous Thromboembolism
12/24
12/24
Woodburn, May
COBRRA AF, NCT04642430: COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation

Recruiting
4
3018
Canada
Apixaban, Eliquis, Rivaroxaban, Xarelto
Ottawa Hospital Research Institute, Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network, Canadian Institutes of Health Research (CIHR)
Atrial Fibrillation
12/26
12/26
CATCH-AF, NCT04302311: Early Diagnosis of Atrial Fibrillation in the Wait-Time Prior to Seeing a Cardiologist

Active, not recruiting
N/A
73
Canada
Holter monitoring, Atrial Fibrillation Diagnostic Testing, Kardia/AliveCor monitoring
Victoria Cardiac Arrhythmia Trials
Atrial Fibrillation, Atrial Fibrillation Paroxysmal, Arrhythmias, Cardiac, Cardiovascular Diseases
10/22
03/24
RPM CIED Tachy, NCT03405740: Remote Patient Management of CIEDs

Recruiting
N/A
1164
Canada
Remote Patient Management, Standard of Care
Ratika Parkash, Cardiac Arrhythmia Network of Canada, Abbott Medical Devices, Medtronic
Cardiac Arrhythmia
02/25
06/25
NCT03636230: Remote Patient Management of CIEDs - Brady Devices

Recruiting
N/A
848
Canada
Remote Monitoring, Standard of care
Ratika Parkash, Cardiac Arrhythmia Network of Canada, Medtronic, Abbott
Pacemaker
02/25
06/25
Samuel, Michelle
END VT, NCT05835791: END - VT Cohort Study

Recruiting
N/A
2454
Canada
Nova Scotia Health Authority, Maritime Heart Centre
Ventricular Tachycardia, Implantable Defibrillator User, ICD
04/28
04/29
Greeley, Suzanne
END VT, NCT05835791: END - VT Cohort Study

Recruiting
N/A
2454
Canada
Nova Scotia Health Authority, Maritime Heart Centre
Ventricular Tachycardia, Implantable Defibrillator User, ICD
04/28
04/29

Download Options